24 May 2013
Keywords: astrazeneca, zomig, impresses, cluster, headache, trial, anglo-swedish
Article | 09 July 2007
Anglo-Swedish drug major AstraZeneca says that data from a study of its pain treatment Zomig (zolmitriptan) shows that the drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 July 2007
2 July 2007
16 July 2007
© 2013 thepharmaletter.com